MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Avinger Cash Conversion Cycle 2011-2025 | AVGR
Annual Cash Conversion Cycle Avinger
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 335 | 299 | 226 | 251 | 248 | 180 | 126 | 241 | 312 | 234 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 335 | 126 | 245 |
Quarterly Cash Conversion Cycle Avinger
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 282 | 281 | 310 | - | 367 | 358 | 383 | - | 335 | 323 | 314 | - | 249 | 213 | 227 | - | 249 | 355 | 226 | - | 245 | 243 | 237 | - | 193 | 147 | 228 | - | 134 | 112 | 172 | 69.6 | 228 | 241 | 208 | 65.8 | 293 | 301 | 348 | 61.4 | 256 | 194 | 135 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 383 | 61.4 | 238 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B |  USA |
 |
Abiomed
ABMD
|
156 | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Apyx Medical Corporation
APYX
|
246 | $ 3.83 | -0.91 % | $ 133 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
263 | $ 304.01 | -1.34 % | $ 8.58 B | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
InMode Ltd.
INMD
|
180 | $ 14.41 | -0.69 % | $ 1.14 B |  Israel |
 |
IRIDEX Corporation
IRIX
|
119 | $ 0.95 | 3.18 % | $ 15.3 M | USA |
 |
IRadimed Corporation
IRMD
|
267 | $ 96.59 | 0.37 % | $ 1.22 B | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 45.43 | 0.66 % | $ 6.77 K | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
100 | $ 128.4 | 2.34 % | $ 223 B | USA |
 |
Boston Scientific Corporation
BSX
|
118 | $ 92.29 | -0.31 % | $ 136 B | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
129 | $ 62.5 | -0.4 % | $ 3.39 B |  Britain |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 2.94 | 2.08 % | $ 110 M |  France |
 |
LENSAR
LNSR
|
147 | $ 11.57 | 0.52 % | $ 133 M | USA |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
|
Cognyte Software Ltd.
CGNT
|
-4.41 | $ 9.66 | -2.03 % | $ 694 M | Israel |
 |
PAVmed
PAVM
|
-111 | $ 0.32 | -3.03 % | $ 2.31 M | USA |
 |
Second Sight Medical Products
EYES
|
-21 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
137 | $ 164.01 | -0.86 % | $ 12.3 B | USA |
 |
Accuray Incorporated
ARAY
|
184 | $ 1.06 | -0.09 % | $ 109 M | USA |
 |
Quanterix Corporation
QTRX
|
173 | $ 7.38 | -2.38 % | $ 277 M | USA |
 |
ClearPoint Neuro
CLPT
|
240 | $ 12.57 | -1.1 % | $ 340 M | USA |
 |
FONAR Corporation
FONR
|
234 | $ 14.63 | -0.81 % | $ 95.9 M | USA |
 |
AxoGen
AXGN
|
195 | $ 30.14 | -0.82 % | $ 1.33 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
218 | $ 40.12 | -1.74 % | $ 1.24 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
723 | $ 17.75 | 0.82 % | $ 410 M | USA |
 |
Globus Medical
GMED
|
319 | $ 86.64 | -0.06 % | $ 11.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 13.61 | 1.42 % | $ 1.05 B | USA |
 |
Aziyo Biologics
AZYO
|
111 | - | 1.37 % | $ 20.5 M | USA |